Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin

被引:133
作者
Hanioka, N
Ozawa, S
Jinno, H
Ando, M
Saito, Y
Sawada, J
机构
[1] Natl Inst Hlth Sci, Div Environm Chem, Setagaya Ku, Tokyo 1588501, Japan
[2] Natl Inst Hlth Sci, Project Team Pharmacogenet, Setagaya Ku, Tokyo 1588501, Japan
关键词
D O I
10.1080/00498250110057341
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The human liver UDP-glucuronosyltransferase (UGT) isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38), the active metabolite of irinotecan (CPT-11), have been studied using microsomes from human liver and insect cells expressing human UGTs (1A1, 1A3, 1A4, 1A6, 1A9, 2B7, 2B15). 2. The glucuronidation of SN-38 was catalysed by UGT1A1, UGT1A3, UGT1A6 and UGT1A9 as well as by liver microsomes. Among these UGT isoforms, UGT1A1 showed the highest activity of SN-38 glucuronidation at both low (1 muM) and high (200 muM) substrate concentrations. The ranking in order of activity at low and high substrate concentrations was UGT1A1 > UGT1A9 > UGT1A6 > UGT1A3 and UGT1A1 > UGT1A3 > UGT1A6 greater than or equal to UGT1A9, respectively. 3. The enzyme kinetics of SN-38 glucuronidation were examined by means of Lineweaver-Burk analysis. The activity of the glucuronidation in liver microsomes exhibits a monophasic kinetic pattern, with an apparent K-m and V-max of 35.9 muM and 134 pmol min(-1) mg(-1) protein, respectively. The UGT isoforms involved in SN-38 glucuronidation could be classified into two types: low-K-m types such as UGT1A1 and UGT1A9, and high-K-m types such as UGT1A3 and UGT1A6, in terms of affinity toward substrate. UGT1A1 had the highest V-max followed by UGT1A3. V-max of UGT1A6 and UGT1A9 were approximately 1/9 to 1/12 of that of UGT1A1. 4. The activity of SN-38 glucuronidation by liver microsomes and UGT1A1 was effectively inhibited by bilirubin. Planar and bulky phenols substantially inhibited the SN-38 glucuronidation activity of liver microsomes and UGT1A9, and/or UGT1A6. Although cholic acid derivatives strongly inhibited the activity of SN-38 glucuronidation by UGT1A3, the inhibition profile did not parallel that in liver microsomes. 5. These results demonstrate that at least four UGT1A isoforms are responsible for SN-38 glucuronidation in human livers, and suggest that the role and contribution of each differ substantially.
引用
收藏
页码:687 / 699
页数:13
相关论文
共 43 条
[1]   The monkey and human uridine diphosphate-glucuronosyltransferase UGT1A9, expressed in steroid target tissues, are estrogen-conjugating enzymes [J].
Albert, C ;
Vallée, M ;
Beaudry, G ;
Bélanger, A ;
Hum, DW .
ENDOCRINOLOGY, 1999, 140 (07) :3292-3302
[2]   The UGT1A1*28 allele is relatively rare in a Japanese population [J].
Ando, Y ;
Chida, M ;
Nakayama, K ;
Saka, H ;
Kamataki, T .
PHARMACOGENETICS, 1998, 8 (04) :357-360
[3]   RELATIONSHIP BETWEEN DEVELOPMENT OF DIARRHEA AND THE CONCENTRATION OF SN-38, AN ACTIVE METABOLITE OF CPT-11, IN THE INTESTINE AND THE BLOOD-PLASMA OF ATHYMIC MICE FOLLOWING INTRAPERITONEAL ADMINISTRATION OF CPT-11 [J].
ARAKI, E ;
ISHIKAWA, M ;
IIGO, M ;
KOIDE, T ;
ITABASHI, M ;
HOSHI, A .
JAPANESE JOURNAL OF CANCER RESEARCH, 1993, 84 (06) :697-702
[4]   THE GENETIC-BASIS OF THE REDUCED EXPRESSION OF BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE-1 IN GILBERTS-SYNDROME [J].
BOSMA, PJ ;
CHOWDHURY, JR ;
BAKKER, C ;
GANTLA, S ;
DEBOER, A ;
OOSTRA, BA ;
LINDHOUT, D ;
TYTGAT, GNJ ;
JANSEN, PLM ;
ELFERINK, RPJO ;
CHOWDHURY, NR .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (18) :1171-1175
[5]   UDP-GLUCURONOSYLTRANSFERASES [J].
BURCHELL, B ;
COUGHTRIE, MWH .
PHARMACOLOGY & THERAPEUTICS, 1989, 43 (02) :261-289
[6]  
Burchell B, 1998, Adv Pharmacol, V42, P335
[7]   SPECIFICITY OF HUMAN UDP-GLUCURONOSYLTRANSFERASES AND XENOBIOTIC GLUCURONIDATION [J].
BURCHELL, B ;
BRIERLEY, CH ;
RANCE, D .
LIFE SCIENCES, 1995, 57 (20) :1819-1831
[8]   Molecular genetic basis of Gilbert's syndrome [J].
Burchell, B ;
Hume, R .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 14 (10) :960-966
[9]   Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38) by the human UDP-glucuronosyltransferases encoded at the UGT1 locus [J].
Ciotti, M ;
Basu, N ;
Brangi, M ;
Owens, IS .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 260 (01) :199-202
[10]  
CLARKE DJ, 1994, HDB EXPT PHARM, V112